Cosmos Health (COSM) vs EnerSyn Global (ESYN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
EnerSyn Global (ESYN) has outperformed Cosmos Health (COSM) over the past year, losing 27.2% versus a loss of 68.8%. EnerSyn Global is the larger company by market cap ($61.2 million vs $32.3 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COSM | ESYN |
|---|---|---|
| Share price | $0.3209 | $2.06 |
| Market cap | $32.29M | $61.24M |
| 1-day change | +0.44% | -1.90% |
| YTD return | -35.56% | +38.26% |
| 1-year return | -68.84% | -27.21% |
| 5-year return | -92.47% | — |
| Forward P/E | 4.58 | — |
| EPS (TTM) | $-0.65 | $-0.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.32 | $2.81 |
| 52-week low | $0.162 | $0.88 |
| Distance from 52-week high | -75.69% | -26.69% |
| Average volume | 4.24M | 164.43K |
| Shares outstanding | 100.63M | 29.73M |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ESYN has outperformed COSM by 41.6 percentage points over the past year.
COSM vs ESYN FAQ
Which is bigger, Cosmos Health or EnerSyn Global?
EnerSyn Global (ESYN) is larger, with a market capitalization of $61.24M compared with $32.29M for Cosmos Health (COSM).
Which stock has performed better over the past year, COSM or ESYN?
ESYN returned -27.21% over the past 12 months, compared with -68.84% for COSM (price return, excluding dividends). Past performance does not predict future results.
Are Cosmos Health and EnerSyn Global in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.